Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes - Université de Lorraine
Journal Articles Journal of Cardiac Failure Year : 2022

Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes

Domains

Cardiology and cardiovascular system
Fichier principal
Vignette du fichier
1-s2.0-S1071916422000021-main.pdf (176.42 Ko) Télécharger le fichier

Erwan BOZEC  : Connect in order to contact the contributor

https://hal.univ-lorraine.fr/hal-03537544

Submitted on : Thursday, January 20, 2022-2:35:38 PM

Last modification on : Monday, October 9, 2023-3:30:03 PM

Long-term archiving on : Thursday, April 21, 2022-7:08:35 PM

Download

Dates and versions

hal-03537544 , version 1 (20-01-2022)

Identifiers

Cite

Milton Packer, Faiez Zannad. Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes. Journal of Cardiac Failure, 2022, S1071-9164 (22), pp.00002-1. ⟨10.1016/j.cardfail.2022.01.001⟩. ⟨hal-03537544⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM UNIV-LORRAINE DCAC-UL BMS-UL
39 View
93 Download

Altmetric

Share

More